UnitedHealth Group's Robust Q2 Performance: Oppenheimer's View On Profit Increase And Revised FY23 Guidance
Portfolio Pulse from Nabaparna Bhattacharya
UnitedHealth Group (UNH) reported Q2 profits of $5.5 billion, up 8% Y/Y, leading Oppenheimer analyst Michael Wiederhorn to reiterate an Outperform rating with a price target of $610. Despite rising costs, UNH's health insurance plans and Optum medical provider businesses grew by double-digit percentages. The company also raised the lower end of its FY2023 guidance range. Post-Q2, Wiederhorn adjusted FY2023/2024/2025 EPS estimates slightly.
July 17, 2023 | 7:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UnitedHealth Group's strong Q2 performance and raised FY2023 guidance may positively impact its stock. The company's diversification, strong track record, and exposure to high-growth businesses are seen as strengths.
UnitedHealth Group's Q2 earnings beat expectations, and the company raised its FY2023 guidance, both of which are positive indicators for the stock. The company's diversification and exposure to high-growth businesses are also seen as strengths, which could further boost investor confidence.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100